PL1680426T3 - Pochodne 1,3,4-triazafenalenu i 1,3,4,6-tetraazafenalenu - Google Patents

Pochodne 1,3,4-triazafenalenu i 1,3,4,6-tetraazafenalenu

Info

Publication number: PL1680426T3
Authority: PL; Poland
Prior art keywords: compounds; phenalene; triaza; treatment; control
Prior art date: 2003-06-10

Application number

PL04729442T

Other languages

English (en)

Inventor

Kin-Chun Luk

Zhuming Zhang

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-10

Filing date

2004-04-26

Publication date

2008-02-29

2004-04-26 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2008-02-29 Publication of PL1680426T3 publication Critical patent/PL1680426T3/pl

Links

YPJREQDHTKXDDE-UHFFFAOYSA-N 2,4,6,8-tetrazatricyclo[7.3.1.05,13]trideca-1(13),2,4,6,9,11-hexaene Chemical class N1=CNC2=CC=CC3=NC=NC1=C32 YPJREQDHTKXDDE-UHFFFAOYSA-N 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 3
201000011510 cancer Diseases 0.000 abstract 2
MMFGLLRFTDSLPQ-UHFFFAOYSA-N 2,4,6-triazatricyclo[7.3.1.05,13]trideca-1(12),3,5,7,9(13),10-hexaene Chemical compound N1=CNC2=CC=CC3=CC=NC1=C32 MMFGLLRFTDSLPQ-UHFFFAOYSA-N 0.000 abstract 1
208000026310 Breast neoplasm Diseases 0.000 abstract 1
102000001301 EGF receptor Human genes 0.000 abstract 1
108060006698 EGF receptor Proteins 0.000 abstract 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
230000001028 anti-proliverative effect Effects 0.000 abstract 1
210000000481 breast Anatomy 0.000 abstract 1
210000001072 colon Anatomy 0.000 abstract 1
208000029742 colonic neoplasm Diseases 0.000 abstract 1
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 abstract 1
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
210000004072 lung Anatomy 0.000 abstract 1
208000037841 lung tumor Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
208000023958 prostate neoplasm Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

PL04729442T 2003-06-10 2004-04-26 Pochodne 1,3,4-triazafenalenu i 1,3,4,6-tetraazafenalenu PL1680426T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US47731803P	2003-06-10	2003-06-10
EP04729442A EP1680426B1 (en)	2003-06-10	2004-04-26	1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
PCT/EP2004/050608 WO2004111055A1 (en)	2003-06-10	2004-04-26	1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives

Publications (1)

Publication Number	Publication Date
PL1680426T3 true PL1680426T3 (pl)	2008-02-29

Family

ID=33551702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04729442T PL1680426T3 (pl)	2003-06-10	2004-04-26	Pochodne 1,3,4-triazafenalenu i 1,3,4,6-tetraazafenalenu

Country Status (15)

Country	Link
US (1)	US7217717B2 (pl)
EP (1)	EP1680426B1 (pl)
JP (1)	JP2006527235A (pl)
KR (1)	KR100753385B1 (pl)
CN (1)	CN100378101C (pl)
AT (1)	ATE373661T1 (pl)
AU (1)	AU2004247418B2 (pl)
BR (1)	BRPI0411126A (pl)
CA (1)	CA2527832A1 (pl)
DE (1)	DE602004009097T2 (pl)
ES (1)	ES2293251T3 (pl)
MX (1)	MXPA05013145A (pl)
PL (1)	PL1680426T3 (pl)
RU (1)	RU2346946C2 (pl)
WO (1)	WO2004111055A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2504690T3 (es) *	2007-10-03	2014-10-08	Eisai Inc.	Compuestos inhibidores de PARP, composiciones y métodos de uso
RU2393162C2 (ru) *	2008-09-12	2010-06-27	Государственное образовательное учреждение высшего профессионального образования САНКТ-ПЕТЕРБУРГСКАЯ ГОСУДАРСТВЕННАЯ ХИМИКО-ФАРМАЦЕВТИЧЕСКАЯ АКАДЕМИЯ (ГОУ ВПО СПХФА Росздрава)	ЗАМЕЩЕННЫЕ 2Н,8Н-1,4-ДИОКСА-9b-АЗАФЕНАЛЕН-2,8-ДИОНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
RU2498986C2 (ru) *	2011-07-20	2013-11-20	Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран)	ТЕТРАЦИАНОЗАМЕЩЕННЫЕ 1,4,9b-ТРИАЗАФЕНАЛЕНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
CN104945406B (zh) *	2015-05-25	2017-10-10	苏州康润医药有限公司	氮杂非那烯‑3‑酮的衍生物、其制备方法及其作为parp抑制剂的应用
CN115894486B (zh) *	2021-09-30	2024-02-09	北京赛特明强医药科技有限公司	一种氢化吡啶并喹唑啉类化合物、组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9300059D0 (en)	1992-01-20	1993-03-03	Zeneca Ltd	Quinazoline derivatives
US5739170A (en) *	1992-09-11	1998-04-14	The Regents Of The University Of California	Inhibitors of metazoan parasite proteases
US5610192A (en) *	1992-09-11	1997-03-11	The Regents Of The University Of California	Inhibitors of metazoan parasite proteases
DE69536015D1 (de)	1995-03-30	2009-12-10	Pfizer Prod Inc	Chinazolinone Derivate
US5747498A (en)	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines
TW436485B (en) *	1997-08-01	2001-05-28	American Cyanamid Co	Substituted quinazoline derivatives
JP4652569B2 (ja)	1998-04-29	2011-03-16	オーエスアイ・ファーマスーティカルズ・インコーポレーテッド	Ｎ−（３−エチニルフェニルアミノ）−６，７−ビス（２−メトキシエトキシ）−４−キナゾリンアミンメシレートの無水物及び一水和物
UA74803C2 (uk)	1999-11-11	2006-02-15	Осі Фармасьютікалз, Інк.	Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
DE60126134T2 (de) *	2000-11-03	2007-10-18	Neurocrine Biosciences, Inc., San Diego	CRF-Rezeptorantagonisten und Verfahren, die damit in Beziehung stehen
EP2173338A1 (en) *	2007-07-06	2010-04-14	OSI Pharmaceuticals, Inc.	Combination anti-cancer therapy

2004
- 2004-04-26 JP JP2006516102A patent/JP2006527235A/ja active Pending
- 2004-04-26 KR KR1020057023531A patent/KR100753385B1/ko not_active Expired - Fee Related
- 2004-04-26 RU RU2006100034/04A patent/RU2346946C2/ru active
- 2004-04-26 DE DE602004009097T patent/DE602004009097T2/de not_active Expired - Fee Related
- 2004-04-26 EP EP04729442A patent/EP1680426B1/en not_active Expired - Lifetime
- 2004-04-26 AU AU2004247418A patent/AU2004247418B2/en not_active Expired - Fee Related
- 2004-04-26 ES ES04729442T patent/ES2293251T3/es not_active Expired - Lifetime
- 2004-04-26 AT AT04729442T patent/ATE373661T1/de not_active IP Right Cessation
- 2004-04-26 WO PCT/EP2004/050608 patent/WO2004111055A1/en not_active Ceased
- 2004-04-26 BR BRPI0411126-5A patent/BRPI0411126A/pt not_active IP Right Cessation
- 2004-04-26 CA CA002527832A patent/CA2527832A1/en not_active Abandoned
- 2004-04-26 PL PL04729442T patent/PL1680426T3/pl unknown
- 2004-04-26 CN CNB2004800162458A patent/CN100378101C/zh not_active Expired - Fee Related
- 2004-04-26 MX MXPA05013145A patent/MXPA05013145A/es active IP Right Grant
- 2004-05-24 US US10/852,735 patent/US7217717B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2004247418A1 (en)	2004-12-23
KR20060017854A (ko)	2006-02-27
US20040254205A1 (en)	2004-12-16
BRPI0411126A (pt)	2006-07-18
KR100753385B1 (ko)	2007-08-30
DE602004009097D1 (de)	2007-10-31
ATE373661T1 (de)	2007-10-15
ES2293251T3 (es)	2008-03-16
RU2006100034A (ru)	2006-08-27
EP1680426A1 (en)	2006-07-19
RU2346946C2 (ru)	2009-02-20
JP2006527235A (ja)	2006-11-30
MXPA05013145A (es)	2006-03-17
CA2527832A1 (en)	2004-12-23
WO2004111055A1 (en)	2004-12-23
DE602004009097T2 (de)	2008-06-19
US7217717B2 (en)	2007-05-15
CN1805964A (zh)	2006-07-19
CN100378101C (zh)	2008-04-02
AU2004247418B2 (en)	2009-11-05
EP1680426B1 (en)	2007-09-19

Publication	Publication Date	Title
TW200407326A (en)	2004-05-16	Pyrimido compounds having antiproliferative activity
GEP20074213B (en)	2007-10-10	Novel inhibitors of kinases
IL147271A0 (en)	2002-08-14	Compounds that bind her2
MXPA04004492A (es)	2004-08-11	Indazolilpirrolotriazinas c-5 modificadas.
TW200420565A (en)	2004-10-16	C-6 modified indazolylpyrrolotriazines
JO2248B1 (en)	2004-10-07	Pirazolobenzodiazepines
MY134783A (en)	2007-12-31	Rho-kinase inhibitors
UA81658C2 (en)	2008-01-25	Substituted pyrimidinones
BRPI0511975A (pt)	2008-01-22	pirazolopirimidinas
MY138851A (en)	2009-08-28	Quinazoline derivatives
DE602004004811D1 (de)	2007-03-29	Chinazolinderivate
GB0309850D0 (en)	2003-06-04	Quinazoline derivatives
DE60215682D1 (de)	2006-12-07	AZAOXOINDOL DERIVATE ALS Trk PROTEIN KINASE HEMMSTOFFE ZUR BEHANDLUNG VON KREBS UND CHRONISCHEM SCHMERZ
WO2000047215A3 (en)	2001-01-18	Methods for anti-tumor therapy
PL342614A1 (en)	2001-06-18	Anticarcinogenic drugs
WO2003017939A3 (en)	2003-11-13	Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
TNSN05188A1 (en)	2007-06-11	4-aminopyrimidine-5-one
PL1680426T3 (pl)	2008-02-29	Pochodne 1,3,4-triazafenalenu i 1,3,4,6-tetraazafenalenu
ATE381930T1 (de)	2008-01-15	Kombinationsmedikationen mit einem selektiven cyclooxygenase-2-inhibitor
WO2005103034A8 (en)	2006-11-02	Novel piperidine substituted diaminothiazoles
TW200612929A (en)	2006-05-01	Novel 2,6-diaminopyridine-3-one derivatives
MX2008002060A (es)	2008-04-16	Nuevas amidas de acido 4-amino-tieno[3,2-c]piridin-7-carboxilico.
BRPI0511826A (pt)	2007-12-26	derivados de 2,4-diaminotiazol-5-ona
WO2003037257A3 (en)	2004-01-22	Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
WO2003080624A3 (en)	2004-03-25	Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases